|
Orthobiologics Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017
|
|||||||||||
| Preis** (Lieferformat): |
Versandkostenfrei ** WICHTIG: Alle Preise sind netto ausgewiesen. Abhängig von Versand- und Leistungsort ist hierauf noch USt. zu entrichten (Deutschland z.Z. 19%). Der korrekte Gesamtendpreis wird Ihnen mit der Angabe Ihrer Rechnungsadresse, USt-ID-Nr. etc. im Bestellverlauf ausgewiesen. Weitere Informationen zu den Bestandteilen des Kaufpreises finden Sie in unseren FAQs. |
Zahlen und Fakten zur Studie: | 233 seiten | |||||||||
| Inhalt der Studie: |
Introduction
GlobalData’s new report, “Orthobiologics Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017” provides key market data on the Orthobiologics market in the BRICS .....
Introduction GlobalData’s new report, “Orthobiologics Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017” provides key market data on the Orthobiologics market in the BRICS countries. The report provides value ($m) data for each segment within four market categories – Bone Graft Substitutes, Bone Allografts, Viscosupplementation and Bone Growth Stimulators. The report also provides company shares and distribution shares data for the overall Orthobiologics market in each of the aforementioned countries. The report is also supplemented with global corporate-level profiles of the key market participants with information on key developments, wherever available. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts. The emerging economies, comprising China, India, Brazil, Russia and South Africa, with a significantly large pool of under-served patients, represent the next big opportunity for the leading medical equipment and devices manufacturers. China remains the world’s most populous country and is consequently home to a large patient base. The country is home to more than 120 million people who are aged 65 or older—a population in continuous need of medical care. India, the second most populous country globally, is home to 1.2 billion people, approximately 5% of which are aged 65 or older. It’s estimated that shortly after 2020, India’s population will surpass China, making it the most populous country in the world. As the population continues to grow and people continue to age, the underlying demand for healthcare is also expected to increase. Scope - Market size data for Orthobiologics market categories – Bone Graft Substitutes, Bone Allografts, Viscosupplementation and Bone Growth Stimulators. - Annualized market revenues ($m) data for each of the segments and sub-segments within the four market categories. Data from 2003 to 2010, forecast forward for seven years to 2017. - 2010 company shares and distribution shares data for the overall Orthobiologics market in each of the aforementioned countries. - Global corporate-level profiles of key companies operating within the Orthobiologics market in BRICS. - Key players covered include DePuy, Inc., Genzyme Corporation, Synthes, Inc., Orthofix International N.V., Medtronic, Inc., Biomet, Inc., DJO Incorporated, Smith & Nephew Plc, Baxter International Inc., Stryker Corporation, Globus Medical, Inc. and WRIGHT MEDICAL GROUP, INC. Highlights Reasons to buy - Develop business strategies by identifying the key market categories and segments poised for strong growth. - Develop market-entry and market expansion strategies. - Design competition strategies by identifying who-stands-where in the Orthobiologics competitive landscape in BRICS. - Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future. - What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize. Report Highlights DePuy, Inc. Genzyme Corporation Synthes, Inc. Orthofix International N.V. Medtronic, Inc. Biomet, Inc. DJO Incorporated Smith & Nephew Plc Baxter International Inc. Stryker Corporation Globus Medical, Inc. Wright Medical Group, Inc Alphatec Holdings, Inc. Ferring Pharmaceuticals Seikagaku Corporation [Studien Infos ausblenden] |
|||||||||||
|
1 Table of Contents 1 Table of Contents 2 1.1 List of Tables 8 1.2 List of Figures 13 2 Introduction 17 2.1 What is This Report About? 17 3 Orthobiologics in BRICS 18 3.1 Orthobiologics, BRICS, Overall Revenue ($m), 2003-2017 18 3.2 Orthobiologics, BRICS, Category Volume (Units), 2003-2017 24 3.3 Orthobiologics, BRICS, Company share (2009-2010) 29 4 Orthobiologics In Brazil 31 4.1 Orthobiologics, Brazil, Overall Revenue ($m), 2003-2017 31 4.2 Orthobiologics, Brazil, Category Volume (Units), 2003-2017 37 4.3 Bone Allografts in Brazil 41 4.3.1 Bone Allografts, Brazil, Overall Revenue (2003-2017) 41 4.4 Bone Graft Substitutes in Brazil 43 4.4.1 Bone Graft Substitutes, Brazil, Overall Revenue (2003-2017) 43 4.4.2 Bone Graft Substitutes, Brazil, Overall Volume (2003-2017) 47 4.4.3 Bone Graft Substitutes, Brazil, Average Price (2003-2017) 51 4.5 Viscosupplementation in Brazil 52 4.5.1 Viscosupplementation, Brazil, Overall Revenue (2003-2017) 52 4.5.2 Viscosupplementation, Brazil, Overall Volume (2003-2017) 54 4.5.3 Viscosupplementation, Brazil, Average Price (2003-2017) 56 4.6 Bone Growth Stimulators in Brazil 57 4.6.1 Bone Growth Stimulators, Brazil, Overall Revenue (2003-2017) 57 4.6.2 Bone Growth Stimulators, Brazil, Overall Volume (2003-2017) 59 4.6.3 Bone Growth Stimulators, Brazil, Average Price (2003-2017) 61 4.7 Orthobiologics, Brazil, Distribution Share (2009-2010) 62 4.8 Orthobiologics, Brazil, Company Share (2009-2010) 63 5 Orthobiologics In Russian Federation 65 5.1 Orthobiologics, Russian Federation, Overall Revenue ($m), 2003-2017 65 5.2 Orthobiologics, Russian Federation, Category Volume (Units), 2003-2017 71 5.3 Bone Graft Substitutes in Russian Federation 76 5.3.1 Bone Graft Substitutes, Russian Federation, Overall Revenue (2003-2017) 76 5.3.2 Bone Graft Substitutes, Russian Federation, Overall Volume (2003-2017) 80 5.3.3 Bone Graft Substitutes, Russian Federation, Average Price (2003-2017) 84 5.4 Bone Allografts in Russian Federation 85 5.4.1 Bone Allografts, Russian Federation, Overall Revenue (2003-2017) 85 5.5 Viscosupplementation in Russian Federation 87 5.5.1 Viscosupplementation, Russian Federation, Overall Revenue (2003-2017) 87 5.5.2 Viscosupplementation, Russian Federation, Overall Volume (2003-2017) 89 5.5.3 Viscosupplementation, Russian Federation, Average Price (2003-2017) 91 5.6 Bone Growth Stimulators In Russian Federation 92 5.6.1 Bone Growth Stimulators, Russian Federation, Overall Revenue (2003-2017) 92 5.6.2 Bone Growth Stimulators, Russian Federation, Overall Volume (2003-2017) 94 5.6.3 Bone Growth Stimulators, Russian Federation, Average Price (2003-2017) 96 5.7 Orthobiologics, Russian Federation, Distribution Share (2009-2010) 97 5.8 Orthobiologics, Russian Federation, Company Share (2009-2010) 98 6 Orthobiologics In India 100 6.1 Orthobiologics, India, Overall Revenue ($m), 2003-2017 100 6.2 Orthobiologics, India, Category Volume (Units), 2003-2017 106 6.3 Bone Graft Substitutes in India 110 6.3.1 Bone Graft Substitutes, India, Overall Revenue (2003-2017) 110 6.3.2 Bone Graft Substitutes, India, Overall Volume (2003-2017) 114 6.3.3 Bone Graft Substitutes, India, Average Price (2003-2017) 117 6.4 Viscosupplementation In India 118 6.4.1 Viscosupplementation, India, Overall Revenue (2003-2017) 118 6.4.2 Viscosupplementation, India, Overall Volume (2003-2017) 120 6.4.3 Viscosupplementation, India, Average Price (2003-2017) 122 6.5 Bone Allografts In India 123 6.5.1 Bone Allografts, India, Overall Revenue (2003-2017) 123 6.6 Bone Growth Stimulators in India 125 6.6.1 Bone Growth Stimulators, India, Overall Revenue (2003-2017) 125 6.6.2 Bone Growth Stimulators, India, Overall Volume (2003-2017) 127 6.6.3 Bone Growth Stimulators, India, Average Price (2003-2017) 129 6.7 Orthobiologics, India, Distribution Share (2009-2010) 130 6.8 Orthobiologics, India, Company Share (2009-2010) 131 7 Orthobiologics In China 133 7.1 Orthobiologics, China, Overall Revenue ($m), 2003-2017 133 7.2 Orthobiologics, China, Category Volume (Units), 2003-2017 139 7.3 Bone Graft Substitutes In China 144 7.3.1 Bone Graft Substitutes, China, Overall Revenue (2003-2017) 144 7.3.2 Bone Graft Substitutes, China, Overall Volume (2003-2017) 148 7.3.3 Bone Graft Substitutes, China, Average Price (2003-2017) 152 7.4 Bone Allografts in China 153 7.4.1 Bone Allografts, China, Overall Revenue (2003-2017) 153 7.5 Viscosupplementation In China 155 7.5.1 Viscosupplementation, China, Overall Revenue (2003-2017) 155 7.5.2 Viscosupplementation, China, Overall Volume (2003-2017) 157 7.5.3 Viscosupplementation, China, Average Price (2003-2017) 159 7.6 Bone Growth Stimulators In China 160 7.6.1 Bone Growth Stimulators, China, Overall Revenue (2003-2017) 160 7.6.2 Bone Growth Stimulators, China, Overall Volume (2003-2017) 162 7.6.3 Bone Growth Stimulators, China, Average Price (2003-2017) 164 7.7 Orthobiologics, China, Distribution Share (2009-2010) 165 7.8 Orthobiologics, China, Company Share (2009-2010) 166 8 Orthobiologics In South Africa 168 8.1 Orthobiologics, South Africa, Overall Revenue ($m), 2003-2017 168 8.2 Orthobiologics, South Africa, Category Volume (Units), 2003-2017 174 8.3 Viscosupplementation In South Africa 179 8.3.1 Viscosupplementation, South Africa, Overall Revenue (2003-2017) 179 8.3.2 Viscosupplementation, South Africa, Overall Volume (2003-2017) 181 8.3.3 Viscosupplementation, South Africa, Average Price (2003-2017) 183 8.4 Bone Graft Substitutes in South Africa 184 8.4.1 Bone Graft Substitutes, South Africa, Overall Revenue (2003-2017) 184 8.4.2 Bone Graft Substitutes, South Africa, Overall Volume (2003-2017) 188 8.4.3 Bone Graft Substitutes, South Africa, Average Price (2003-2017) 191 8.5 Bone Allografts in South Africa 192 8.5.1 Bone Allografts, South Africa, Overall Revenue (2003-2017) 192 8.6 Bone Growth Stimulators In South Africa 194 8.6.1 Bone Growth Stimulators, South Africa, Overall Revenue (2003-2017) 194 8.6.2 Bone Growth Stimulators, South Africa, Overall Volume (2003-2017) 196 8.6.3 Bone Growth Stimulators, South Africa, Average Price (2003-2017) 198 8.7 Orthobiologics, South Africa, Distribution Share (2009-2010) 199 8.8 Orthobiologics, South Africa, Company Share (2009-2010) 200 9 Overview of Key Companies in BRICS Orthobiologics Market 202 9.1 DePuy, Inc. 202 9.1.1 Company Overview 202 9.1.2 Share in the BRICS Orthobiologics Market 203 9.2 Genzyme Corporation 204 9.2.1 Company Overview 204 9.2.2 Share in the BRICS Orthobiologics Market 205 9.3 Synthes, Inc. 206 9.3.1 Company Overview 206 9.3.2 Share in the BRICS Orthobiologics Market 207 9.4 Orthofix International N.V. 208 9.4.1 Company Overview 208 9.4.2 Share in the BRICS Orthobiologics Market 209 9.5 Medtronic, Inc. 210 9.5.1 Company Overview 210 9.5.2 Share in the BRICS Orthobiologics Market 211 9.6 Biomet, Inc. 212 9.6.1 Company Overview 212 9.6.2 Share in the BRICS Orthobiologics Market 213 9.7 DJO Incorporated 214 9.7.1 Company Overview 214 9.7.2 Share in the BRICS Orthobiologics Market 215 9.8 Smith & Nephew Plc 216 9.8.1 Company Overview 216 9.8.2 Share in the BRICS Orthobiologics Market 217 9.9 Baxter International Inc. 218 9.9.1 Company Overview 218 9.9.2 Share in the BRICS Orthobiologics Market 219 9.10 Stryker Corporation 220 9.10.1 Company Overview 220 9.10.2 Share in the BRICS Orthobiologics Market 221 9.11 Globus Medical, Inc. 222 9.11.1 Company Overview 222 9.11.2 Share in the BRICS Orthobiologics Market 222 9.12 Wright Medical Group, Inc 223 9.12.1 Company Overview 223 9.12.2 Share in the BRICS Orthobiologics Market 224 9.13 Alphatec Holdings, Inc. 225 9.13.1 Company Overview 225 9.14 Ferring Pharmaceuticals 225 9.14.1 Company Overview 225 9.15 Seikagaku Corporation 225 9.15.1 Company Overview 225 9.16 Osteotech, Inc. (Inactive) 226 9.16.1 Company Overview 226 10 Appendix 227 10.1 Definitions of Markets Covered in the Report 228 10.1.1 Orthobiologics 228 10.2 Research Methodology 230 10.3 Secondary Research 230 10.4 Primary Research 231 10.5 Models 231 10.6 Forecasts 232 10.7 Expert Panels 232 10.8 GlobalData Consulting 232 10.9 Currency Conversion 233 10.10 Contact Us 233 10.11 Disclaimer 233 [Inhaltsverzeichnis ausblenden] |
||||||||||||
|
1.1 List of Tables Table 1: Orthobiologics, BRICS, Overall Revenue ($m), 2003-2017 19 Table 2: Orthobiologics, BRICS, Overall Revenue ($m), Historic, 2003-2010 21 Table 3: Orthobiologics, BRICS, Overall Revenue ($m), Forecast, 2010-2017 23 Table 4: Orthobiologics, BRICS, Category Volume (Units), 2003-2017 24 Table 5: Orthobiologics, BRICS, Category Volume (Units), Historic, 2003-2010 26 Table 6: Orthobiologics, BRICS, Category Volume (Units), Forecast, 2010-2017 28 Table 7: Orthobiologics, BRICS, Company share by Revenue ($m), 2009-2010 30 Table 8: Orthobiologics, Brazil, Overall Revenue ($m), 2003-2017 32 Table 9: Orthobiologics, Brazil, Overall Revenue ($m), Historic, 2003-2010 34 Table 10: Orthobiologics, Brazil, Overall Revenue ($m), Forecast, 2010-2017 36 Table 11: Orthobiologics, Brazil, Category Volume (Units), 2003-2017 37 Table 12: Orthobiologics, Brazil, Category Volume (Units), Historic, 2003-2010 39 Table 13: Orthobiologics, Brazil, Category Volume (Units), Forecast, 2010-2017 40 Table 14: Bone Allografts, Brazil, Revenue ($m), Historic, 2003-2010 41 Table 15: Bone Allografts, Brazil, Revenue ($m), Forecast, 2010-2017 42 Table 16: Bone Graft Substitutes, Brazil, Revenue ($m) by Segment, Historic, 2003-2010 44 Table 17: Bone Graft Substitutes, Brazil, Revenue ($m) by Segment, Forecast, 2010-2017 46 Table 18: Bone Graft Substitutes, Brazil, Volume (Units) by Segment, Historic, 2003-2010 48 Table 19: Bone Graft Substitutes, Brazil, Volume (Units) by Segment, Forecast, 2010-2017 50 Table 20: Bone Graft Substitutes, Brazil, Average Price ($), Historic, 2003-2010 51 Table 21: Bone Graft Substitutes, Brazil, Average Price ($), Forecast, 2010-2017 51 Table 22: Viscosupplementation, Brazil, Revenue ($m), Historic, 2003-2010 52 Table 23: Viscosupplementation, Brazil, Revenue ($m), Forecast, 2010-2017 53 Table 24: Viscosupplementation, Brazil, Volume (Units), Historic, 2003-2010 54 Table 25: Viscosupplementation, Brazil, Volume (Units), Forecast, 2010-2017 55 Table 26: Viscosupplementation, Brazil, Average Price ($), Historic, 2003-2010 56 Table 27: Viscosupplementation, Brazil, Average Price ($), Forecast, 2010-2017 56 Table 28: Bone Growth Stimulators, Brazil, Revenue ($m), Historic, 2003-2010 57 Table 29: Bone Growth Stimulators, Brazil, Revenue ($m), Forecast, 2010-2017 58 Table 30: Bone Growth Stimulators, Brazil, Volume (Units), Historic, 2003-2010 59 Table 31: Bone Growth Stimulators, Brazil, Volume (Units), Forecast, 2010-2017 60 Table 32: Bone Growth Stimulators, Brazil, Average Price ($), Historic, 2003-2010 61 Table 33: Bone Growth Stimulators, Brazil, Average Price ($), Forecast, 2010-2017 61 Table 34: Orthobiologics, Brazil, Distribution Share by Revenue ($m), 2009-2010 62 Table 35: Orthobiologics, Brazil, Company Share by Revenue ($m), 2009-2010 64 Table 36: Orthobiologics, Russian Federation, Overall Revenue ($m), 2003-2017 66 Table 37: Orthobiologics, Russian Federation, Overall Revenue ($m), Historic, 2003-2010 68 Table 38: Orthobiologics, Russian Federation, Overall Revenue ($m), Forecast, 2010-2017 70 Table 39: Orthobiologics, Russian Federation, Category Volume (Units), 2003-2017 71 Table 40: Orthobiologics, Russian Federation, Category Volume (Units), Historic, 2003-2010 73 Table 41: Orthobiologics, Russian Federation, Category Volume (Units), Forecast, 2010-2017 75 Table 42: Bone Graft Substitutes, Russian Federation, Revenue ($m) by Segment, Historic, 2003-2010 77 Table 43: Bone Graft Substitutes, Russian Federation, Revenue ($m) by Segment, Forecast, 2010-2017 79 Table 44: Bone Graft Substitutes, Russian Federation, Volume (Units) by Segment, Historic, 2003-2010 81 Table 45: Bone Graft Substitutes, Russian Federation, Volume (Units) by Segment, Forecast, 2010-2017 83 Table 46: Bone Graft Substitutes, Russian Federation, Average Price ($), Historic, 2003-2010 84 Table 47: Bone Graft Substitutes, Russian Federation, Average Price ($), Forecast, 2010-2017 84 Table 48: Bone Allografts, Russian Federation, Revenue ($m), Historic, 2003-2010 85 Table 49: Bone Allografts, Russian Federation, Revenue ($m), Forecast, 2010-2017 86 Table 50: Viscosupplementation, Russian Federation, Revenue ($m), Historic, 2003-2010 87 Table 51: Viscosupplementation, Russian Federation, Revenue ($m), Forecast, 2010-2017 88 Table 52: Viscosupplementation, Russian Federation, Volume (Units) Historic, 2003-2010 89 Table 53: Viscosupplementation, Russian Federation, Volume (Units), Forecast, 2010-2017 90 Table 54: Viscosupplementation, Russian Federation, Average Price ($), Historic, 2003-2010 91 Table 55: Viscosupplementation, Russian Federation, Average Price ($), Forecast, 2010-2017 91 Table 56: Bone Growth Stimulators, Russian Federation, Revenue ($m), Historic, 2003-2010 92 Table 57: Bone Growth Stimulators, Russian Federation, Revenue ($m), Forecast, 2010-2017 93 Table 58: Bone Growth Stimulators, Russian Federation, Volume (Units), Historic, 2003-2010 94 Table 59: Bone Growth Stimulators, Russian Federation, Volume (Units), Forecast, 2010-2017 95 Table 60: Bone Growth Stimulators, Russian Federation, Average Price ($), Historic, 2003-2010 96 Table 61: Bone Growth Stimulators, Russian Federation, Average Price ($), Forecast, 2010-2017 96 Table 62: Orthobiologics, Russian Federation, Distribution Share by Revenue ($m), 2009-2010 97 Table 63: Orthobiologics, Russian Federation, Company Share by Revenue ($m), 2009-2010 99 Table 64: Orthobiologics, India, Overall Revenue ($m), 2003-2017 101 Table 65: Orthobiologics, India, Overall Revenue ($m), Historic, 2003-2010 103 Table 66: Orthobiologics, India, Overall Revenue ($m), Forecast, 2010-2017 105 Table 67: Orthobiologics, India, Category Volume (Units), 2003-2017 106 Table 68: Orthobiologics, India, Category Volume (Units), Historic, 2003-2010 108 Table 69: Orthobiologics, India, Category Volume (Units), Forecast, 2010-2017 109 Table 70: Bone Graft Substitutes, India, Revenue ($m) by Segment, Historic, 2003-2010 111 Table 71: Bone Graft Substitutes, India, Revenue ($m) by Segment, Forecast, 2010-2017 113 Table 72: Bone Graft Substitutes, India, Volume (Units) by Segment, Historic, 2003-2010 115 Table 73: Bone Graft Substitutes, India, Volume (Units) by Segment, Forecast, 2010-2017 116 Table 74: Bone Graft Substitutes, India, Average Price ($), Historic, 2003-2010 117 Table 75: Bone Graft Substitutes, India, Average Price ($), Forecast, 2010-2017 117 Table 76: Viscosupplementation, India, Revenue ($m), Historic, 2003-2010 118 Table 77: Viscosupplementation, India, Revenue ($m), Forecast, 2010-2017 119 Table 78: Viscosupplementation, India, Volume (Units), Historic, 2003-2010 120 Table 79: Viscosupplementation, India, Volume (Units), Forecast, 2010-2017 121 Table 80: Viscosupplementation, India, Average Price ($), Historic, 2003-2010 122 Table 81: Viscosupplementation, India, Average Price ($), Forecast, 2010-2017 122 Table 82: Bone Allografts, India, Revenue ($m), Historic, 2003-2010 123 Table 83: Bone Allografts, India, Revenue ($m), Forecast, 2010-2017 124 Table 84: Bone Growth Stimulators, India, Revenue ($m), Historic, 2003-2010 125 Table 85: Bone Growth Stimulators, India, Revenue ($m), Forecast, 2010-2017 126 Table 86: Bone Growth Stimulators, India, Volume (Units), Historic, 2003-2010 127 Table 87: Bone Growth Stimulators, India, Volume (Units), Forecast, 2010-2017 128 Table 88: Bone Growth Stimulators, India, Average Price ($), Historic, 2003-2010 129 Table 89: Bone Growth Stimulators, India, Average Price ($), Forecast, 2010-2017 129 Table 90: Orthobiologics, India, Distribution Share by Revenue ($m), 2009-2010 130 Table 91: Orthobiologics, India, Company Share by Revenue ($m), 2009-2010 132 Table 92: Orthobiologics, China, Overall Revenue ($m), 2003-2017 134 Table 93: Orthobiologics, China, Overall Revenue ($m), Historic, 2003-2010 136 Table 94: Orthobiologics, China, Overall Revenue ($m), Forecast, 2010-2017 138 Table 95: Orthobiologics, China, Category Volume (Units), 2003-2017 139 Table 96: Orthobiologics, China, Category Volume (Units), Historic, 2003-2010 141 Table 97: Orthobiologics, China, Category Volume (Units), Forecast, 2010-2017 143 Table 98: Bone Graft Substitutes, China, Revenue ($m) by Segment, Historic, 2003-2010 145 Table 99: Bone Graft Substitutes, China, Revenue ($m) by Segment, Forecast, 2010-2017 147 Table 100: Bone Graft Substitutes, China, Volume (Units) by Segment, Historic, 2003-2010 149 Table 101: Bone Graft Substitutes, China, Volume (Units) by Segment, Forecast, 2010-2017 151 Table 102: Bone Graft Substitutes, China, Average Price ($), Historic, 2003-2010 152 Table 103: Bone Graft Substitutes, China, Average Price ($), Forecast, 2010-2017 152 Table 104: Bone Allografts, China, Revenue ($m), Historic, 2003-2010 153 Table 105: Bone Allografts, China, Revenue ($m) by Segment, Forecast, 2010-2017 154 Table 106: Viscosupplementation, China, Revenue ($m), Historic, 2003-2010 155 Table 107: Viscosupplementation, China, Revenue ($m), Forecast, 2010-2017 156 Table 108: Viscosupplementation, China, Volume (Units), Historic, 2003-2010 157 Table 109: Viscosupplementation, China, Volume (Units), Forecast, 2010-2017 158 Table 110: Viscosupplementation, China, Average Price ($), Historic, 2003-2010 159 Table 111: Viscosupplementation, China, Average Price ($), Forecast, 2010-2017 159 Table 112: Bone Growth Stimulators, China, Revenue ($m), Historic, 2003-2010 160 Table 113: Bone Growth Stimulators, China, Revenue ($m), Forecast, 2010-2017 161 Table 114: Bone Growth Stimulators, China, Volume (Units), Historic, 2003-2010 162 Table 115: Bone Growth Stimulators, China, Volume (Units), Forecast, 2010-2017 163 Table 116: Bone Growth Stimulators, China, Average Price ($), Historic, 2003-2010 164 Table 117: Bone Growth Stimulators, China, Average Price ($), Forecast, 2010-2017 164 Table 118: Orthobiologics, China, Distribution Share by Revenue ($m), 2009-2010 165 Table 119: Orthobiologics, China, Company Share by Revenue ($m), 2009-2010 167 Table 120: Orthobiologics, South Africa, Overall Revenue ($m), 2003-2017 169 Table 121: Orthobiologics, South Africa, Overall Revenue ($m), Historic, 2003-2010 171 Table 122: Orthobiologics, South Africa, Overall Revenue ($m), Forecast, 2010-2017 173 Table 123: Orthobiologics, South Africa, Category Volume (Units), 2003-2017 174 Table 124: Orthobiologics, South Africa, Category Volume (Units), Historic, 2003-2010 176 Table 125: Orthobiologics, South Africa, Category Volume (Units), Forecast, 2010-2017 178 Table 126: Viscosupplementation, South Africa, Revenue ($m), Historic, 2003-2010 179 Table 127: Viscosupplementation, South Africa, Revenue ($m), Forecast, 2010-2017 180 Table 128: Viscosupplementation, South Africa, Volume (Units), Historic, 2003-2010 181 Table 129: Viscosupplementation, South Africa, Volume (Units), Forecast, 2010-2017 182 Table 130: Viscosupplementation, South Africa, Average Price ($), Historic, 2003-2010 183 Table 131: Viscosupplementation, South Africa, Average Price ($), Forecast, 2010-2017 183 Table 132: Bone Graft Substitutes, South Africa, Revenue ($m) by Segment, Historic, 2003-2010 185 Table 133: Bone Graft Substitutes, South Africa, Revenue ($m) by Segment, Forecast, 2010-2017 187 Table 134: Bone Graft Substitutes, South Africa, Volume (Units) by Segment, Historic, 2003-2010 189 Table 135: Bone Graft Substitutes, South Africa, Volume (Units) by Segment, Forecast, 2010-2017 190 Table 136: Bone Graft Substitutes, South Africa, Average Price ($), Historic, 2003-2010 191 Table 137: Bone Graft Substitutes, South Africa, Average Price ($), Forecast, 2010-2017 191 Table 138: Bone Allografts, South Africa, Revenue ($m), Historic, 2003-2010 192 Table 139: Bone Allografts, South Africa, Revenue ($m), Forecast, 2010-2017 193 Table 140: Bone Growth Stimulators, South Africa, Revenue ($m), Historic, 2003-2010 194 Table 141: Bone Growth Stimulators, South Africa, Revenue ($m), Forecast, 2010-2017 195 Table 142: Bone Growth Stimulators, South Africa, Volume (Units), Historic, 2003-2010 196 Table 143: Bone Growth Stimulators, South Africa, Volume (Units), Forecast, 2010-2017 197 Table 144: Bone Growth Stimulators, South Africa, Average Price ($), Historic, 2003-2010 198 Table 145: Bone Growth Stimulators, South Africa, Average Price ($), Forecast, 2010-2017 198 Table 146: Orthobiologics, South Africa, Distribution Share by Revenue ($m), 2009-2010 199 Table 147: Orthobiologics, South Africa, Company Share by Revenue ($m), 2009-2010 201 Table 148: DePuy, Inc., Revenue ($m), BRICS Orthobiologics Market, 2010 203 Table 149: Genzyme Corporation, Revenue ($m), BRICS Orthobiologics Market, 2010 205 Table 150: Synthes, Inc., Revenue ($m), BRICS Orthobiologics Market, 2010 207 Table 151: Orthofix International N.V., Revenue ($m), BRICS Orthobiologics Market, 2010 209 Table 152: Medtronic, Inc., Revenue ($m), BRICS Orthobiologics Market, 2010 211 Table 153: Biomet, Inc., Revenue ($m), BRICS Orthobiologics Market, 2010 213 Table 154: DJO Incorporated Revenue ($m), BRICS Orthobiologics Market, 2010 215 Table 155: Smith & Nephew Plc, Revenue ($m), BRICS Orthobiologics Market, 2010 217 Table 156: Baxter International Inc., Revenue ($m), BRICS Orthobiologics Market, 2010 219 Table 157: Stryker Corporation, Revenue ($m), BRICS Orthobiologics Market, 2010 221 Table 158: Globus Medical, Inc., Revenue ($m), BRICS Orthobiologics Market, 2010 222 Table 159: Wright Medical Group, Inc., Revenue ($m), BRICS Orthobiologics Market, 2010 224 Table 160: USD to Local Currency, BRICS, Average Exchange Rate, 2003-2010 233 1.2 List of Figures Figure 1: Orthobiologics, BRICS, Overall Revenue ($m), 2003-2017 18 Figure 2: Orthobiologics, BRICS, Overall Revenue ($m), Historic, 2003-2010 20 Figure 3: Orthobiologics, BRICS, Overall Revenue ($m), Forecast, 2010-2017 22 Figure 4: Orthobiologics, BRICS, Category Volume (Units), 2003-2017 24 Figure 5: Orthobiologics, BRICS, Category Volume (Units), Historic, 2003-2010 25 Figure 6: Orthobiologics, BRICS, Category Volume (Units), Forecast, 2010-2017 27 Figure 7: Orthobiologics, BRICS, Company share (%), 2010 29 Figure 8: Orthobiologics, Brazil, Overall Revenue ($m), 2003-2017 31 Figure 9: Orthobiologics, Brazil, Overall Revenue ($m), Historic, 2003-2010 33 Figure 10: Orthobiologics, Brazil, Overall Revenue ($m), Forecast, 2010-2017 35 Figure 11: Orthobiologics, Brazil, Category Volume (Units), 2003-2017 37 Figure 12: Orthobiologics, Brazil, Category Volume (Units), Historic, 2003-2010 38 Figure 13: Orthobiologics, Brazil, Category Volume (Units), Forecast, 2010-2017 40 Figure 14: Bone Allografts, Brazil, Revenue ($m), Historic, 2003-2010 41 Figure 15: Bone Allografts, Brazil, Revenue ($m), Forecast, 2010-2017 42 Figure 16: Bone Graft Substitutes, Brazil, Revenue ($m) by Segment, Historic, 2003-2010 43 Figure 17: Bone Graft Substitutes, Brazil, Revenue ($m) by Segment, Forecast, 2010-2017 45 Figure 18: Bone Graft Substitutes, Brazil, Volume (Units) by Segment, Historic, 2003-2010 47 Figure 19: Bone Graft Substitutes, Brazil, Volume (Units) by Segment, Forecast, 2010-2017 49 Figure 20: Viscosupplementation, Brazil, Revenue ($m), Historic, 2003-2010 52 Figure 21: Viscosupplementation, Brazil, Revenue ($m), Forecast, 2010-2017 53 Figure 22: Viscosupplementation, Brazil, Volume (Units), Historic, 2003-2010 54 Figure 23: Viscosupplementation, Brazil, Volume (Units), Forecast, 2010-2017 55 Figure 24: Bone Growth Stimulators, Brazil, Revenue ($m), Historic, 2003-2010 57 Figure 25: Bone Growth Stimulators, Brazil, Revenue ($m), Forecast, 2010-2017 58 Figure 26: Bone Growth Stimulators, Brazil, Volume (Units), Historic, 2003-2010 59 Figure 27: Bone Growth Stimulators, Brazil, Volume (Units), Forecast, 2010-2017 60 Figure 28: Orthobiologics, Brazil, Company Share (%), 2010 63 Figure 29: Orthobiologics, Russian Federation, Overall Revenue ($m), 2003-2017 65 Figure 30: Orthobiologics, Russian Federation, Overall Revenue ($m), Historic, 2003-2010 67 Figure 31: Orthobiologics, Russian Federation, Overall Revenue ($m), Forecast, 2010-2017 69 Figure 32: Orthobiologics, Russian Federation, Category Volume (Units), 2003-2017 71 Figure 33: Orthobiologics, Russian Federation, Category Volume (Units), Historic, 2003-2010 72 Figure 34: Orthobiologics, Russian Federation, Category Volume (Units), Forecast, 2010-2017 74 Figure 35: Bone Graft Substitutes, Russian Federation, Revenue ($m) by Segment, Historic, 2003-2010 76 Figure 36: Bone Graft Substitutes, Russian Federation, Revenue ($m) by Segment, Forecast, 2010-2017 78 Figure 37: Bone Graft Substitutes, Russian Federation, Volume (Units) by Segment, Historic, 2003-2010 80 Figure 38: Bone Graft Substitutes, Russian Federation, Volume (Units) by Segment, Forecast, 2010-2017 82 Figure 39: Bone Allografts, Russian Federation, Revenue ($m), Historic, 2003-2010 85 Figure 40: Bone Allografts, Russian Federation, Revenue ($m), Forecast, 2010-2017 86 Figure 41: Viscosupplementation, Russian Federation, Revenue ($m), Historic, 2003-2010 87 Figure 42: Viscosupplementation, Russian Federation, Revenue ($m), Forecast, 2010-2017 88 Figure 43: Viscosupplementation, Russian Federation, Volume (Units), Historic, 2003-2010 89 Figure 44: Viscosupplementation, Russian Federation, Volume (Units), Forecast, 2010-2017 90 Figure 45: Bone Growth Stimulators, Russian Federation, Revenue ($m), Historic, 2003-2010 92 Figure 46: Bone Growth Stimulators, Russian Federation, Revenue ($m), Forecast, 2010-2017 93 Figure 47: Bone Growth Stimulators, Russian Federation, Volume (Units), Historic, 2003-2010 94 Figure 48: Bone Growth Stimulators, Russian Federation, Volume (Units), Forecast, 2010-2017 95 Figure 49: Orthobiologics, Russian Federation, Company Share (%), 2010 98 Figure 50: Orthobiologics, India, Overall Revenue ($m), 2003-2017 100 Figure 51: Orthobiologics, India, Overall Revenue ($m), Historic, 2003-2010 102 Figure 52: Orthobiologics, India, Overall Revenue ($m), Forecast, 2010-2017 104 Figure 53: Orthobiologics, India, Category Volume (Units), 2003-2017 106 Figure 54: Orthobiologics, India, Category Volume (Units), Historic, 2003-2010 107 Figure 55: Orthobiologics, India, Category Volume (Units), Forecast, 2010-2017 109 Figure 56: Bone Graft Substitutes, India, Revenue ($m) by Segment, Historic, 2003-2010 110 Figure 57: Bone Graft Substitutes, India, Revenue ($m) by Segment, Forecast, 2010-2017 112 Figure 58: Bone Graft Substitutes, India, Volume (Units) by Segment, Historic, 2003-2010 114 Figure 59: Bone Graft Substitutes, India, Volume (Units) by Segment, Forecast, 2010-2017 116 Figure 60: Viscosupplementation, India, Revenue ($m), Historic, 2003-2010 118 Figure 61: Viscosupplementation, India, Revenue ($m), Forecast, 2010-2017 119 Figure 62: Viscosupplementation, India, Volume (Units), Historic, 2003-2010 120 Figure 63: Viscosupplementation, India, Volume (Units), Forecast, 2010-2017 121 Figure 64: Bone Allografts, India, Revenue ($m), Historic, 2003-2010 123 Figure 65: Bone Allografts, India, Revenue ($m), Forecast, 2010-2017 124 Figure 66: Bone Growth Stimulators, India, Revenue ($m), Historic, 2003-2010 125 Figure 67: Bone Growth Stimulators, India, Revenue ($m), Forecast, 2010-2017 126 Figure 68: Bone Growth Stimulators, India, Volume (Units), Historic, 2003-2010 127 Figure 69: Bone Growth Stimulators, India, Volume (Units), Forecast, 2010-2017 128 Figure 70: Orthobiologics, India, Company Share (%), 2010 131 Figure 71: Orthobiologics, China, Overall Revenue ($m), 2003-2017 133 Figure 72: Orthobiologics, China, Overall Revenue ($m), Historic, 2003-2010 135 Figure 73: Orthobiologics, China, Overall Revenue ($m), Forecast, 2010-2017 137 Figure 74: Orthobiologics, China, Category Volume (Units), 2003-2017 139 Figure 75: Orthobiologics, China, Category Volume (Units), Historic, 2003-2010 140 Figure 76: Orthobiologics, China, Category Volume (Units), Forecast, 2010-2017 142 Figure 77: Bone Graft Substitutes, China, Revenue ($m) by Segment, Historic, 2003-2010 144 Figure 78: Bone Graft Substitutes, China, Revenue ($m) by Segment, Forecast, 2010-2017 146 Figure 79: Bone Graft Substitutes, China, Volume (Units) by Segment, Historic, 2003-2010 148 Figure 80: Bone Graft Substitutes, China, Volume (Units) by Segment, Forecast, 2010-2017 150 Figure 81: Bone Allografts, China, Revenue ($m), Historic, 2003-2010 153 Figure 82: Bone Allografts, China, Revenue ($m), Forecast, 2010-2017 154 Figure 83: Viscosupplementation, China, Revenue ($m), Historic, 2003-2010 155 Figure 84: Viscosupplementation, China, Revenue ($m), Forecast, 2010-2017 156 Figure 85: Viscosupplementation, China, Volume (Units), Historic, 2003-2010 157 Figure 86: Viscosupplementation, China, Volume (Units), Forecast, 2010-2017 158 Figure 87: Bone Growth Stimulators, China, Revenue ($m), Historic, 2003-2010 160 Figure 88: Bone Growth Stimulators, China, Revenue ($m), Forecast, 2010-2017 161 Figure 89: Bone Growth Stimulators, China, Volume (Units), Historic, 2003-2010 162 Figure 90: Bone Growth Stimulators, China, Volume (Units), Forecast, 2010-2017 163 Figure 91: Orthobiologics, China, Company Share (%), 2010 166 Figure 92: Orthobiologics, South Africa, Overall Revenue ($m), 2003-2017 168 Figure 93: Orthobiologics, South Africa, Overall Revenue ($m), Historic, 2003-2010 170 Figure 94: Orthobiologics, South Africa, Overall Revenue ($m), Forecast, 2010-2017 172 Figure 95: Orthobiologics, South Africa, Category Volume (Units), 2003-2017 174 Figure 96: Orthobiologics, South Africa, Category Volume (Units), Historic, 2003-2010 175 Figure 97: Orthobiologics, South Africa, Category Volume (Units), Forecast, 2010-2017 177 Figure 98: Viscosupplementation, South Africa, Revenue ($m), Historic, 2003-2010 179 Figure 99: Viscosupplementation, South Africa, Revenue ($m), Forecast, 2010-2017 180 Figure 100: Viscosupplementation, South Africa, Volume (Units), Historic, 2003-2010 181 Figure 101: Viscosupplementation, South Africa, Volume (Units), Forecast, 2010-2017 182 Figure 102: Bone Graft Substitutes, South Africa, Revenue ($m) by Segment, Historic, 2003-2010 184 Figure 103: Bone Graft Substitutes, South Africa, Revenue ($m) by Segment, Forecast, 2010-2017 186 Figure 104: Bone Graft Substitutes, South Africa, Volume (Units) by Segment, Historic, 2003-2010 188 Figure 105: Bone Graft Substitutes, South Africa, Volume (Units) by Segment, Forecast, 2010-2017 190 Figure 106: Bone Allografts, South Africa, Revenue ($m), Historic, 2003-2010 192 Figure 107: Bone Allografts, South Africa, Revenue ($m), Forecast, 2010-2017 193 Figure 108: Bone Growth Stimulators, South Africa, Revenue ($m), Historic, 2003-2010 194 Figure 109: Bone Growth Stimulators, South Africa, Revenue ($m), Forecast, 2010-2017 195 Figure 110: Bone Growth Stimulators, South Africa, Volume (Units), Historic, 2003-2010 196 Figure 111: Bone Growth Stimulators, South Africa, Volume (Units), Forecast, 2010-2017 197 Figure 112: Orthobiologics, South Africa, Company Share (%), 2010 200 Figure 113: DePuy, Inc., Company Share (%), BRICS Orthobiologics Market, 2010 203 Figure 114: Genzyme Corporation, Company Share (%), BRICS Orthobiologics Market, 2010 205 Figure 115: Synthes, Inc., Company Share (%), BRICS Orthobiologics Market, 2010 207 Figure 116: Orthofix International N.V., Company Share (%), BRICS Orthobiologics Market, 2010 209 Figure 117: Medtronic, Inc., Company Share (%), BRICS Orthobiologics Market, 2010 211 Figure 118: Biomet, Inc., Company Share (%), BRICS Orthobiologics Market, 2010 213 Figure 119: DJO Incorporated Company Share (%), BRICS Orthobiologics Market, 2010 215 Figure 120: Smith & Nephew Plc, Company Share (%), BRICS Orthobiologics Market, 2010 217 Figure 121: Baxter International Inc., Company Share (%), BRICS Orthobiologics Market, 2010 219 Figure 122: Stryker Corporation, Company Share (%), BRICS Orthobiologics Market, 2010 221 Figure 123: Wright Medical Group, Inc., Company Share (%), BRICS Orthobiologics Market, 2010 224 [Tabellenverzeichnis ausblenden] |
||||||||||||
| Hinweis: | * Der Rechnungsbetrag für diese Studie wird in $ (Dollar) ausgewiesen. Kunden aus dem Inland bekommen von uns eine Rechnung in Euro, umgerechnet zum letztwöchigen Schlusskurs | |||||||||||
|
|
||||||||||||
